Clinical Diabetes · 2022 · 16 citations · 28 references
MedicinePharmacotherapyBehavioral MedicineClinical MedicineDiabetologyDiabetes ManagementDiabetes MellitusDiabetes Self-managementLifestyle MedicineMedication DeprescribingMedication ManagementClinical RemissionDeprescribing BarriersDeprescribing Outcomes AssessmentDiabetes Medication DeprescribingDiabetes Medication UseGlucose-lowering TherapySecond RemissionType 2 Diabetes Treatment
This study is a qualitative case series of lifestyle medicine practitioners' protocols for medication de-escalation in the context of reduced need for glucose-lowering medications due to lifestyle modifications. Increasing numbers of lifestyle medicine practitioners report achieving reductions in medications among patients with type 2 diabetes, and in some cases remission, but limited data exist on the clinical decision-making process used to determine when and how medications are deprescribed. Practitioners interviewed here provide accounts of their deprescribing protocols. This information can serve as pilot data for other practitioners seeking examples of how deprescribing in the context of lifestyle medicine treatment is conducted.
28
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman, Christoph Wanner, John M. Lachin et al. · New England Journal of Medicine · 2015 · 12K citations · Full text
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine · 2016 · 7.3K citations · Full text
Economic Costs of Diabetes in the U.S. in 2017
Diabetes Care · 2018 · 2.6K citations · Full text
Michael E. J. Lean, W. S. Leslie, Alison C. Barnes et al. · The Lancet Diabetes & Endocrinology · 2019 · 953 citations · Full text